Brief: Seastar Medical Reports Enrollment Momentum In Its Pivotal Adult AKI Trial
25/09/2024 13:40
Sept 25 (Reuters) - SeaStar Medical Holding Corp
ICU.O :
* SEASTAR MEDICAL REPORTS ENROLLMENT MOMENTUM IN ITS PIVOTAL
ADULT
AKI TRIAL
* SEASTAR MEDICAL HOLDING CORP - NEUTRALIZE-AKI TRIAL
EXPECTED TO
ENROLL UP TO 200 ADULTS
Source text for Eikon: ID:nGNX2gDGVm
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview